Key Takeaways
- Kansas Medicaid through KanCare has covered MAT for opioid use disorder since October 2020, and KDHE’s overdose response toolkit actively directs communities toward providers offering methadone, buprenorphine, and naltrexone.3,4
- MAT is not swapping one drug for another. Medications like buprenorphine, methadone, naltrexone, and acamprosate steady brain chemistry without producing a high, and detoxing without them raises overdose risk.1
- When comparing Kansas programs, weigh whether counseling is built into the prescription, whether detox, residential, PHP, IOP, and aftercare connect under one roof, and whether MD and RN staff supervise across stages.
- Before committing, call providers with a short list of questions about medications prescribed, counseling integration, KanCare or insurance billing, detox monitoring, and aftercare planning to confirm the program fits your situation.
What Medication-Assisted Treatment Actually Is (And What It Isn’t)
If you’re reading this, you or someone you love is probably tired. Tired of the cycle, tired of white-knuckling it, tired of promises that didn’t stick. That exhaustion is real, and it deserves a real answer. Medication-assisted treatment, usually shortened to MAT, is one of those answers.
Here’s the plain version. MAT uses FDA-approved medications to help your body and brain settle down enough that recovery becomes possible. For opioid use disorder, those medications are methadone, buprenorphine, and naltrexone. For alcohol use disorder, they’re naltrexone, acamprosate, and disulfiram. The medications lower cravings, ease withdrawal, and in some cases block the effect of the substance entirely.
But MAT is not a pill you swallow while everything else stays the same. National guidelines describe it as medication combined with behavioral therapy, not medication instead of it. The medication quiets the storm in your nervous system. The counseling helps you figure out what to do with the quiet.1
What MAT isn’t matters just as much. It isn’t a shortcut. It isn’t a punishment. It isn’t a sign you failed at abstinence, and it isn’t only for people whose situation feels “bad enough.” The CDC is direct about this: trying to detox from opioids without medication support actually raises your risk of overdose and death if you use again. That’s not a scare tactic. That’s the reason MAT exists in the first place.1
You don’t have to have this all figured out today. You just have to keep reading, keep asking questions, and let the information do some of the heavy lifting for a minute.
The Fear Behind the Question: ‘Am I Just Trading One Drug for Another?’
Let’s sit with this one for a minute, because it’s the question almost everyone asks, out loud or in their head. If you’ve heard it from a family member, a sponsor, or your own inner voice, you’re not alone. It’s a fair thing to wonder. And it deserves more than a defensive answer.
Here’s what’s actually happening in your body. Opioid use disorder changes the way your brain regulates pain, stress, and reward. Alcohol use disorder does something similar. Those changes don’t disappear when the substance leaves your system. That’s why the first few days sober can feel unbearable, and why willpower alone rarely wins that fight for long.
MAT medications work on the same receptors your brain has already been adapting to. But they do it in a steady, controlled way, without the highs and the crashes. Buprenorphine and methadone quiet opioid cravings without producing the euphoria that drives use. Naltrexone blocks the reward signal entirely. Acamprosate helps calm the nervous system in early alcohol recovery. None of these are getting you high. They’re helping your brain stop screaming.
If you still feel uneasy about that, that’s okay. You don’t have to love the idea. You just have to be willing to talk to someone who can walk you through what MAT would look like for your specific situation, at your specific stage. Curiosity counts. Asking counts. You’re already doing the hard part.
How Kansas Covers and Endorses MAT
Medicaid, KanCare, and What’s Paid For
Cost is one of the biggest reasons people put off getting help. If you’ve been quietly running numbers in your head, worrying about what a month of treatment could do to your rent or your family’s savings, you’re not being dramatic. You’re being realistic. And there’s actually some good news buried in Kansas policy that you may not have heard.
Kansas Medicaid, delivered through KanCare, covers medication-assisted treatment for opioid use disorder. The federal government approved Kansas’s State Plan Amendment adding MAT services for OUD, with coverage effective October 1, 2020, for any Medicaid beneficiary who meets medical necessity criteria. In plain terms: if you qualify for KanCare and a licensed provider says MAT is the right clinical fit for you, the medication side of your care has a funding path.3
What that doesn’t automatically tell you is how it works at a specific facility. Some programs bill Medicaid directly. Others accept private insurance, TRICARE for veterans, or a mix. A few offer sliding-scale options for people who fall between the cracks. The only reliable way to know what your out-of-pocket cost will be is to ask the admissions team to verify your benefits before you commit to anything.
You don’t need to solve the whole financial picture today. You just need to know that a payment path exists, and that asking about it is not a rude question. It’s the right one.
State-Level Endorsement Through KDHE
Coverage is one piece. Endorsement is another. It matters that the state agencies who set the tone for public health in Kansas are actively naming MAT as part of the response, not treating it as a fringe option.
The Kansas Department of Health and Environment published its 2024 Overdose Spike Alert Community Response Toolkit specifically to help communities respond when overdose numbers rise. That toolkit tells providers and community leaders to promote Certified Community Behavioral Health Clinics that offer methadone, buprenorphine, and naltrexone, and it states directly that MAT for opioid use disorder can be effective alongside other treatment types in helping people regain control and reduce overdose risk. That’s not a hedge. That’s a state health department saying MAT belongs in the toolkit.4
Layer that on top of the federal picture. The CDC’s clinical guidance is clear that medication for opioid use disorder should be combined with behavioral therapy, and that trying to detox without medication support raises the risk of overdose and death. So the message from every direction lines up. Kansas policy funds MAT. Kansas public health endorses it. National clinical guidance recommends it as standard of care.1
If you’ve been carrying quiet doubt about whether MAT is a “real” treatment or something second-tier, let this settle it. The people paid to protect public health in your state have already answered that question. Your job now is much smaller. You just have to find the door and walk through it.
The Medications Used for Opioid Use Disorder
Three medications carry most of the weight in treating opioid use disorder. Each one works differently, and the right choice depends on your history, your health, and what your life looks like day to day. You don’t have to pick one before you talk to a clinician. But it helps to know what you’re actually being offered.
| Medication | Description |
|---|---|
| Buprenorphine | A partial opioid agonist, which is a technical way of saying it activates the same brain receptors opioids use, but only partway. It quiets cravings and prevents withdrawal without producing the high. It has a ceiling effect, meaning higher doses don’t keep amplifying the response, which lowers overdose risk. You may hear it called by brand names like Suboxone when it’s combined with naloxone. It can be prescribed in an office-based setting, which makes it easier to access than methadone in a lot of Kansas communities. |
| Methadone | A full opioid agonist that has been used for decades. It’s dispensed through federally regulated opioid treatment programs, usually daily at first. That structure can feel like a lot, but for people with long or heavy opioid histories, that daily contact is often part of what makes it work. Methadone is well-studied and effective at reducing illicit opioid use and overdose deaths. |
| Naltrexone | Takes a different approach. It’s an opioid antagonist, meaning it blocks the receptors entirely. If you use opioids while it’s active, you don’t feel the effect. The extended-release injectable form, given monthly, removes the daily decision. Naltrexone requires you to be fully detoxed from opioids before starting, which is a real hurdle and one your care team will help you plan around. |
All three are named in Kansas’s own public health response, with the KDHE toolkit specifically directing communities toward providers offering methadone, buprenorphine, and naltrexone. And the CDC is clear that trying to detox without any of these medications actually raises overdose risk if you use again, because your tolerance drops fast. That’s why the standard of care isn’t “medication or willpower.” It’s medication paired with counseling, chosen with a clinician who knows your full picture.1,4
You’re not expected to walk in knowing which one is right for you. That conversation is the appointment.
The Medications Used for Alcohol Use Disorder
Alcohol use disorder has its own set of tools, and they work differently than the opioid medications. If drinking is the substance pulling you under, this is your section. Four medications are FDA-approved for AUD: naltrexone (oral and long-acting injectable), acamprosate, and disulfiram. The first two do most of the work in current practice.8
| Medication | Description |
|---|---|
| Acamprosate | Helps calm the nervous system’s response to alcohol withdrawal. It’s usually started after you’ve stopped drinking and helps your brain re-regulate over the following weeks and months. It’s typically taken three times a day, which sounds like a lot until you compare it to how often alcohol was running your schedule. |
| Naltrexone | Blocks the reward signal alcohol produces in the brain. Drinking on naltrexone still tastes like drinking, but the pull to keep going, and the buzz that used to feel like relief, gets much quieter. It comes as a daily pill or a monthly injection. For people who want one less decision to make each morning, the injectable version can be a game-changer. |
| Disulfiram | Takes a different route. It makes you physically sick if you drink while it’s in your system. It was once first-line, but newer clinical guidance no longer places it there because of adherence and safety concerns. It still has a role for some people, usually those with strong external support and a clear commitment to abstinence. |
Here’s a concrete number that helps cut through the noise. In studies looking at return to drinking over 12 to 52 weeks, the Number Needed to Treat, or NNT, was 12 for acamprosate and 20 for naltrexone. NNT is a clinical shorthand: it’s how many people have to take the medication for one additional person to avoid returning to drinking compared to placebo. A lower number means the medication helps more people, more often. Both work. Acamprosate’s edge in that particular measure is real, but the right choice for you depends on your drinking pattern, your health history, and your goals, whether that’s full abstinence or cutting back.9
One important note. Nearly all the studies behind these numbers included counseling or other psychosocial support alongside the medication. The pill isn’t doing this alone. It’s doing it with you, and with the people helping you build a life that doesn’t need the drink.10
Why Counseling Sits Next to the Prescription, Not Behind It
Here’s something worth saying out loud. The medication is not the whole treatment. It never was.
When researchers study MAT and report the results you read about, almost every one of those studies also included counseling, therapy, or some kind of psychosocial support alongside the pill or the injection. The effect sizes people quote are the combined effect. Medication plus talking to someone who knows what they’re doing. Take one away and you’re not looking at the same picture anymore.10
That matters because the medication handles a specific job. It steadies your brain chemistry, quiets the cravings, and closes some of the doors that used to swing open every time you were stressed, lonely, or bored. What it does not do is teach you how to sit through a hard evening without the thing you used to reach for. It does not repair the relationships that took hits during active use. It does not sort through the trauma that may have been feeding the addiction in the first place. Those are the counseling jobs.
National clinical guidance treats this as a package deal, not a preference. The CDC frames evidence-based OUD treatment as medications combined with behavioral therapy, and notes that a recovery plan built around both increases your chance of success. Kansas policy points the same direction, with the KDHE toolkit steering people toward clinics that pair MOUD with the wider set of behavioral health services.2,4
What this looks like in practice is simpler than it sounds. You take the medication as prescribed. You show up for the sessions, individual and group. You let the two sides of your care talk to each other, which usually means your prescriber and your therapist are actually in the same building or at least the same chart. When medication and counseling are running on separate tracks, small problems get missed. When they’re running together, you get caught.
If the idea of therapy makes you tense, that’s normal. You don’t have to be good at it on day one. You just have to keep the chair warm.
Where MAT Fits Inside a Full Continuum of Care
Picture MAT as one instrument in an orchestra, not a solo. It plays a specific part, at a specific volume, at a specific moment. The rest of the music matters too, and none of it works if the instruments aren’t playing together.
A full continuum of care is what it sounds like. It’s a set of treatment stages that step up or step down based on what your body and mind need at any given point. In a well-integrated program, MAT can show up at nearly every one of those stages, adjusted for where you are.
Medically-monitored detox is usually the first stop if you’re still using. This is where MD and RN staff manage the physical side of coming off opioids or alcohol, using medication to keep withdrawal from becoming dangerous. Detox alone is not treatment, and the CDC is direct that detoxification without medications for opioid use disorder actually raises the risk of overdose and death if you use again. That’s why MAT often starts here, not after.1
Residential treatment is where a lot of the deeper work happens. You’re living on-site, away from the triggers and habits that were shaping your days. MAT continues under medical supervision while counseling, group work, and daily structure take on the parts of recovery that medication alone can’t touch.
Partial hospitalization (PHP) and intensive outpatient (IOP) are the step-downs. You spend part of each day or several days a week in structured programming, but you’re also starting to rebuild a life outside of it. Your medication regimen keeps going. So does the counseling. The intensity shifts. The support doesn’t disappear.
Outpatient treatment and aftercare are the long tail. This is where a lot of people quietly stop showing up in the old data, because their formal treatment ended and no one was tracking them anymore. In a real continuum, this stage is still active. Your prescriber checks in. Your counselor is still on the schedule. Alumni support keeps you connected to people who understand what the past year cost you.
The through-line is medical oversight. MD and RN staff following the same person across stages means dose adjustments, side effects, co-occurring conditions, and life changes all get caught by someone who already knows your story. That continuity is the difference between MAT as a prescription and MAT as part of your care.
What to Ask Any Kansas Provider Before You Commit
You don’t have to be a clinician to ask smart questions. You just need a short list you can pull out during that first phone call, when your heart is pounding and your brain has gone blank. Save this one somewhere you can find it.2,3
- Which MAT medications do you prescribe, and who prescribes them? A real MAT program has MD or advanced-practice clinicians actively involved, not just a therapist who refers out for the prescription.
- Is counseling built in, or is it a separate referral? National guidance treats medication and behavioral therapy as one plan, not two. If your prescriber and your therapist have never spoken, that’s a gap.
- What levels of care do you offer under one roof? Detox, residential, PHP, IOP, outpatient, and aftercare should connect. Moving between facilities during early recovery is where a lot of people fall out.
- Who monitors me during detox? Ask specifically about MD and RN coverage. Opioid and alcohol withdrawal can turn medically serious quickly.
- Do you take KanCare or my insurance? Kansas Medicaid covers MAT for OUD when medical necessity is met, but every provider handles billing differently. Ask them to verify your benefits before you commit.
- What happens after I finish the intensive phase? A program that can’t answer this clearly is handing you back to yourself too soon.
If a provider gets uncomfortable with these questions, that’s information. The right team will welcome them. Asking is not being difficult. It’s being ready.
A Kansas Option to Consider: Holland Pathways
If you’re looking for a Kansas program that treats MAT the way this article has described it, Holland Pathways in Wichita is worth a conversation. The 64-bed campus is built around a full continuum: medically-monitored detox, 60-day residential care, partial hospitalization, intensive outpatient, standard outpatient, and alumni support. MD and RN staff supervise the medical side across those stages, which is the kind of oversight national guidance points toward when it frames MOUD as part of a broader recovery plan rather than a standalone prescription.2
What tends to matter to people calling for the first time is what happens after detox. At Holland Pathways, Masters-level clinicians handle trauma-informed counseling for co-occurring conditions like PTSD, depression, and anxiety, with specialized programming for veterans. Wearable biotech from Huml Health tracks sleep, stress, and heart rate in real time, giving clinicians data to adjust your care as your body responds. That’s the operational answer to “will someone actually be watching me?”
You don’t have to commit to anything to have the conversation. Call Holland Pathways to talk through whether MAT is appropriate for your situation, what your coverage looks like, and what the next step could be. Asking is a step. It counts.
Start Your MAT Recovery Conversation Today
Connect with a caring team to discuss next steps for MAT treatment and structured support.
Frequently Asked Questions
Is MAT just replacing one drug with another?
No. MAT medications work on the same brain receptors affected by opioids or alcohol, but in a steady, controlled way that doesn’t produce a high. They quiet cravings so recovery becomes possible. The CDC notes that trying to detox without these medications actually raises overdose risk if you use again. Supported recovery is safer than unsupported recovery.1
Does Kansas Medicaid cover MAT?
Yes. Kansas Medicaid, delivered through KanCare, covers MAT services for opioid use disorder for beneficiaries who meet medical necessity criteria, with coverage effective October 1, 2020. How each facility handles billing varies, so ask the admissions team to verify your specific benefits before you commit to a program.3
Which medications are used for opioid and alcohol use disorder?
For opioid use disorder, the three FDA-approved medications are methadone, buprenorphine, and naltrexone, all named in Kansas’s own public health response. For alcohol use disorder, four medications are FDA-approved: oral naltrexone, long-acting injectable naltrexone, acamprosate, and disulfiram, though current guidance places acamprosate and naltrexone as first-line.4,8
Do I still need counseling if I’m taking MAT medication?
Yes, and this matters. Almost every clinical study behind MAT included counseling alongside the medication, meaning the results people quote reflect both working together. The medication steadies your brain chemistry. Counseling helps you rebuild the parts of life the addiction was covering for. One without the other is a shorter answer to a longer problem.10
How long will I need to stay on MAT?
There’s no fixed timeline. Some people take MAT medications for months, others for years, and some indefinitely. The decision is clinical, not moral. Your prescriber will weigh your history, how you’re responding, and what your life looks like. Stopping too early is one of the most common reasons people return to use, so this call gets made together.
What should I ask a Kansas MAT provider before starting treatment?
Ask which medications they prescribe and who supervises. Ask whether counseling is built in or referred out, since national guidance treats them as one plan. Ask what levels of care they offer under one roof, who monitors you during detox, whether they accept KanCare or your insurance, and what aftercare looks like. Good programs welcome these questions.2
References
- Opioid Use Disorder: Treating | Overdose Prevention. https://www.cdc.gov/overdose-prevention/hcp/clinical-care/opioid-use-disorder-treating.html
- Treatment of Opioid Use Disorder | Overdose Prevention. https://www.cdc.gov/overdose-prevention/treatment/opioid-use-disorder.html
- Kansas State Plan Amendment (SPA) – KS-25-0024. https://www.medicaid.gov/medicaid/spa/downloads/KS-25-0024.pdf
- Substance Use Disorder & Overdose Prevention Toolkit (2024 Overdose Spike Alert Community Response Toolkit). https://www.kdhe.ks.gov/DocumentCenter/View/43233/2024-Overdose-Spike-Alert-Community-Response-Toolkit-PDF
- Treatment of Alcohol Use Disorder – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK561234/
- A Review of the Literature – TIP 49: Pharmacotherapy for Alcohol Use Disorders. https://www.ncbi.nlm.nih.gov/books/NBK65178/
- Executive Summary – Pharmacotherapy for Adults With Alcohol Use Disorder. https://www.ncbi.nlm.nih.gov/books/NBK597425/
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Clinical Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC7391072/
- Pharmacologic treatment of alcohol use disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC7430770/
- Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings. https://www.ncbi.nlm.nih.gov/books/NBK208590/
- Alcohol Use Disorder: The Role of Medication in Recovery. https://pmc.ncbi.nlm.nih.gov/articles/PMC8184096/
- Pharmacotherapies and personalized medicine for alcohol use disorder. https://pmc.ncbi.nlm.nih.gov/articles/PMC7586357/
- Long-term drug treatment of patients with alcohol dependence. https://pmc.ncbi.nlm.nih.gov/articles/PMC4653998/
